LEVOX | VSTSX | LEVOX / VSTSX | |
Total Expense Ratio | 1.10 | 0.01 | 11,000% |
Annual Report Gross Expense Ratio | 1.11 | 0.01 | 11,100% |
Fund Existence | 20 years | 9 years | - |
Gain YTD | -8.068 | 0.785 | -1,028% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 5000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 46.8M | 1.72T | 0% |
Annual Yield % from dividends | 0.25 | 1.38 | 18% |
Returns for 1 year | -57.61 | 11.12 | -518% |
Returns for 3 years | -76.99 | 49.97 | -154% |
Returns for 5 years | -74.78 | 96.47 | -78% |
Returns for 10 years | -72.98 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ECHSX | 12.77 | N/A | N/A |
Eaton Vance Worldwide Health Sci C | |||
VTCIX | 152.07 | N/A | N/A |
Vanguard Tax-Managed Capital App I | |||
MNMRX | 14.47 | N/A | N/A |
Manning & Napier Pro-Blend Mod Term R | |||
JANRX | 18.76 | -0.19 | -1.00% |
Janus Henderson Global Select D | |||
WALSX | 13.65 | -0.31 | -2.22% |
Wasatch Long/Short Alpha Investor |